Adage Capital Partners’s Aerie Pharmaceuticals AERI Stock Holding History

Adage Capital Partners’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-390,100	Closed	-$7.5M	–	777
2019 Q3	$7.5M	Sell	390,100 -1,310,000	-77%	-$30M	0.02%	576
2019 Q2	$50.2M	Sell	1,700,100 -555,900	-25%	-$21.4M	0.13%	205
2019 Q1	$107M	Sell	2,256,000 -890,411	-28%	-$39.2M	0.27%	94
2018 Q4	$114M	Buy	3,146,411 +496,411	+19%	+$23.3M	0.31%	82
2018 Q3	$163M	Sell	2,650,000 -150,000	-5%	-$9.64M	0.36%	63
2018 Q2	$189M	Sell	2,800,000 -271,635	-9%	-$15.2M	0.43%	52
2018 Q1	$167M	Buy	3,071,635 +460,000	+18%	+$25.7M	0.39%	65
2017 Q4	$156M	Sell	2,611,635 -463,365	-15%	-$28.1M	0.35%	71
2017 Q3	$149M	Sell	3,075,000 -375,000	-11%	-$20.5M	0.36%	68
2017 Q2	$181M	Buy	3,450,000 +1,350,000	+64%	+$62.9M	0.44%	45
2017 Q1	$95.2M	Sell	2,100,000 -100,000	-5%	-$4.46M	0.24%	112
2016 Q4	$83.3M	Buy	2,200,000 +549,216	+33%	+$20.8M	0.23%	119
2016 Q3	$62.3M	Sell	1,650,784 -449,216	-21%	-$9.91M	0.17%	153
2016 Q2	$37M	Buy	2,100,000 +75,000	+4%	+$1.21M	0.1%	244
2016 Q1	$24.6M	Buy	2,025,000 +400,000	+25%	+$6.33M	0.07%	320
2015 Q4	$39.6M	Buy	1,625,000 +125,000	+8%	+$2.92M	0.1%	233
2015 Q3	$26.6M	Buy	+1,500,000	New	+$27.2M	0.07%	318

Other funds holding AERI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Adage Capital Partners's AERI Position: Q4 2019 in Review

Adage Capital Partners sold out of Aerie Pharmaceuticals (AERI) in Q4 2019, closing a stake of 390,100 shares — an estimated $7.5M sold.

Adage Capital Partners first reported a position in AERI in Q3 2015 and held it in 17 quarters. The position peaked at $189M in Q2 2018. 167 funds tracked by Wall St. Rank hold AERI as of Q4 2019.

Adage Capital Partners reported no remaining Aerie Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Adage Capital Partners sold 390,100 Aerie Pharmaceuticals shares in Q4 2019, an estimated $7.5M.
Adage Capital Partners first reported a position in Aerie Pharmaceuticals in Q3 2015 and held it in 17 quarters.
Adage Capital Partners's Aerie Pharmaceuticals position peaked at $189M in Q2 2018.
167 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2019.

Based on Adage Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.